SciELO - Scientific Electronic Library Online

 
vol.34 número4Efecto de la administración de vitamina K en las complicaciones asociadas con enfermedad hepática crónica terminalDiferencias en el grosor de la grasa epicárdica en pacientes con diabetes mellitus tipo 2, prediabetes y sujetos no diabéticos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Medicina interna de México

versión impresa ISSN 0186-4866

Resumen

LOPEZ-HERNANDEZ, Marco Antonio  y  MONTOYA-ESCUTIA, Patricia. Association of depression severity with adherence to the first scheme of antiretroviral treatment. Med. interna Méx. [online]. 2018, vol.34, n.4, pp.557-560. ISSN 0186-4866.  http://dx.doi.org/10.24245/mim.v34i4.1828.

OBJECTIVE

To compare the rate of adherence to antiretroviral therapy in the first line in patients with depressive disorders vs those without depression.

MATERIAL AND METHOD

A prospective study was done from January to June 2016 in patients from the HIV clinics of the Regional General Hospital No. 1 of IMSS, and the General Hospital Tacuba, in antiretroviral treatment with a first scheme, started more than six months ago, excluding patients with neurological disorders, different from depression, patients with diagnosis and/or previous treatment of depression. Patients answered the Beck questionnaire for depression and the SMAQ scale for adherence.

RESULTS

180 patients were evaluated with a first antiretroviral treatment regimen. It was found that 126 (70%) patients did not present depression, 36 (20%) presented depression, 15 (8.3%) presented moderate depression and 3 (1.7%) presented severe depression. Non-adherence was observed in 15.8% of patients without depression versus 55.5% of patients with depression (p = 0.01). The adherence of patients with depression was inversely proportional to the severity of the same. Regarding the viral load under the limit of suppression (< 40 copies/mL) in patients without depression, a higher proportion of patients with a viral load higher than 40 copies/mL was observed: 17.4% vs 15.8%, considered non-adherent by the SMAQ questionnaire.

CONCLUSIONS

Adherence decreases with the severity of depression in patients, putting the effectiveness of antiretroviral treatment at risk.

Palabras llave : Antiretroviral therapy; Depression; HIV.

        · resumen en Español     · texto en Español     · Español ( pdf )